Site Search
Search Results
‘Delaware Advocacy Day’ Brings Patient Advocates to Dover to Discuss Affordability of Biomarker Testing
... his administration. He visited with advocates today to hear firsthand why removing barriers to this vital tool is essential to patients and the health care and equity landscape in Delaware. Advocates from both ACS CAN and ALZ are hopeful that state lawmakers join the governor in prioritizing ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...
Delaware Patients Now One Step Closer to Expanding Access to Precision Medicine
... treatment at the right time. While its application has predominantly been in oncology, the power of biomarker testing extends beyond cancer care to the treatment of diseases such as arthritis, other autoimmune conditions and rare diseases. And so, a robust, disease-agnostic coalition ... relations director for ACS CAN in Delaware, responded, “Today’s vote brings Delaware patients one step closer to accessing the personalized care they need without worrying about whether their insurance will cover the testing that can guide critical treatment decisions. We are grateful ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer ...
Delaware Senate Passes Legislation to Improve Access to Biomarker Testing & Precision Medicine
... the last few decades and is increasingly important in the treatment of other conditions, providing access to targeted treatment and tailoring care to a person’s individual disease. When American Cancer Society Cancer Action Network (ACS CAN) volunteer Matt Wilson underwent treatment for ... to prioritize patients and pass the proposal without delay. “For thousands of patients in Delaware, biomarker testing has meant more effective care and better outcomes, offering renewed hope. Yet, too many people still struggle to access this testing due to barriers, including inadequate ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...
Expand Access to Biomarker Testing in Delaware
... more Delaware residents can benefit from this important testing! Video of maggies_biomarker_story What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...